Reset
Showing 2 of 2 academic articles

Analysing criteria for price and reimbursement of orphan drugs in Spain

Xavier Badia, Alicia Gil, José Luis Poveda-Andrés, John Shepherd et al. • Farmacia Hospitalaria (2019)

Objective: There are differences between countries regarding data requirements for orphan drug evaluation and it is also unknown which criteria might determine the price and reimbursement decision. This study aimed to identify the key c...

DOAJ Open Access (DOAJ) DOI: 10.7399/fh.11147

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Marcin Czech et al. • Frontiers in Pharmacology (2019)

BackgroundReimbursement policies influence access of patients to orphan drugs in the European countries.ObjectivesTo provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making proce...

DOAJ Open Access (DOAJ) DOI: 10.3389/fphar.2019.00487